Bovie Medical entered into a global sales channel partnership agreement with CONMED for its PlazXact™ Ablator, which will be marketed as the UltrAblator Bipolar® series effective in March 2017.
The PlazXact ablator is a sterile, single-use device for the cutting, coagulating and ablation of soft tissue in arthroscopic procedures.
The agreement complements ConMed’s strategy to provide a full range of competitively-priced ablator products that cover a variety of arthroscopic procedures for small and large joints.
Bovie Medical entered into a global sales channel partnership agreement with CONMED for its PlazXact™ Ablator, which will be marketed as the UltrAblator Bipolar® series effective in March 2017.
The PlazXact ablator is a sterile, single-use device for the cutting, coagulating and ablation of soft tissue in arthroscopic procedures.
The...
Bovie Medical entered into a global sales channel partnership agreement with CONMED for its PlazXact™ Ablator, which will be marketed as the UltrAblator Bipolar® series effective in March 2017.
The PlazXact ablator is a sterile, single-use device for the cutting, coagulating and ablation of soft tissue in arthroscopic procedures.
The agreement complements ConMed’s strategy to provide a full range of competitively-priced ablator products that cover a variety of arthroscopic procedures for small and large joints.
Copy to clipboard 
